Dan began his research career at the University of Warwick. After a year in Warwick Clinical Trials Unit, Dan joined Warwick Evidence, one of NICE’s TAR teams. Dan remained in Warwick Evidence until the team’s move to University of Birmingham in January 2025, forming the Birmingham Centre for Evidence and Implementation Science.
Previously, Dan completed undergraduate and postgraduate studies at the University of Reading and the University of Leciester respectively. His PhD was completed whilst working full-time as a member of Warwick Evidence, evaluating the performance of routinely used methods of survival extrapolation to predict future survival through Monte Carlo simulation. He has extensive experience of critiquing company submissions and models, with a focus on the implementation of statistical methods into the economic model. He has particular interest in oncology appraisals.
Dan now leads the BCEIS TAR team, and is a member of NICE Technology Appraisal Committee B.